Subsequent studies showed that SEPT9 was frequently deleted in sporadic ovarian tumors [5] or amplified in breast cancer [6]; it was suggested that the gene might be a candidate ovarian tumor suppressor gene that may also act like an oncogene. This evidence concerns the gene SEPTIN9 and breast cancer.